For investors of any type, consistently outperforming the market over the long term is a worthwhile goal. While achieving this is challenging, it is not impossible. This article will focus on two companies—Intuitive Surgical (ISRG) and Meta Platforms (META)—which, thanks to their unique competitive advantages and growth drivers, are well-positioned to deliver market-beating returns in the coming years.
Despite facing challenges over the past year, including tariff pressures and increasing competition in the robot-assisted surgery field, Intuitive Surgical’s long-term growth prospects remain solid. The company’s core strength lies in its continuously evolving da Vinci surgical system, which has now reached its fifth generation. The latest system incorporates key technologies such as force feedback, significantly enhancing surgeons’ tactile perception during operations. This improvement is expected to lead to better patient outcomes, thereby driving demand from healthcare institutions.
Growth is not solely driven by hardware innovation. By securing approvals for additional surgical indications for its systems, the company can effectively increase procedure volumes, a key driver of revenue growth. In the face of external pressures such as tariffs, Intuitive Surgical’s proven clinical value and extensive installed base afford it strong pricing power to offset rising costs. Furthermore, although competitors like Medtronic’s Hugo system have gained approval, the overall penetration of robot-assisted surgery remains low, leaving ample room for Intuitive Surgical’s expansion. These factors collectively support its robust outlook.
After reporting strong quarterly results, Meta Platforms’ stock came under pressure due to market concerns over the returns from its substantial investments in artificial intelligence. However, the company’s AI investments are already demonstrating tangible results. Its AI algorithms have significantly boosted user engagement across its platforms, while automated advertising tools have also contributed to revenue and profit growth. The company’s long-term goal is to fully automate the advertising campaign process by the end of 2026. Leveraging its vast ecosystem of over 3 billion daily active users, this effort is expected to continue delivering value.
The market has previously raised doubts about the company’s strategic execution, such as setbacks related to its ambitious metaverse initiatives. Yet Meta has demonstrated strong adaptability by controlling costs and refocusing on its core advertising business, ultimately strengthening its overall operations. This flexibility will help the company navigate potential challenges in the future. Currently, if its deep investments in AI can be effectively integrated with its massive user platform, it has the potential to drive sustained financial performance, supporting long-term stock appreciation.
In summary, Intuitive Surgical’s deep expertise and innovative pace in medical technology, combined with Meta Platforms’ ability to leverage AI to enhance and monetize its vast social ecosystem, form the core rationale for their potential to continue outperforming the market until 2031.
